Parsons Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-5,619
| Closed | -$255K | – | 336 |
|
|
2020
Q1 | $255K | Sell |
5,619
-553
| -9% | -$25.1K | 0.03% | 272 |
|
|
2019
Q4 | $402K | Hold |
6,172
| – | – | 0.04% | 265 |
|
|
2019
Q3 | $383K | Sell |
6,172
-160
| -3% | -$9.93K | 0.04% | 264 |
|
|
2019
Q2 | $451K | Sell |
6,332
-72
| -1% | -$5.13K | 0.05% | 250 |
|
|
2019
Q1 | $502K | Buy |
6,404
+48
| +0.8% | +$3.76K | 0.05% | 240 |
|
|
2018
Q4 | $538K | Buy |
6,356
+569
| +10% | +$48.2K | 0.07% | 223 |
|
|
2018
Q3 | $991K | Hold |
5,787
| – | – | 0.1% | 183 |
|
|
2018
Q2 | $748K | Sell |
5,787
-91
| -2% | -$11.8K | 0.08% | 212 |
|
|
2018
Q1 | $606K | Hold |
5,878
| – | – | 0.07% | 231 |
|
|
2017
Q4 | $502K | Hold |
5,878
| – | – | 0.06% | 262 |
|
|
2017
Q3 | $499K | Hold |
5,878
| – | – | 0.06% | 247 |
|
|
2017
Q2 | $445K | Hold |
5,878
| – | – | 0.05% | 256 |
|
|
2017
Q1 | $388K | Sell |
5,878
-1,804
| -23% | -$119K | 0.05% | 266 |
|
|
2016
Q4 | $487K | Sell |
7,682
-200
| -3% | -$12.7K | 0.06% | 228 |
|
|
2016
Q3 | $502K | Buy |
7,882
+4,924
| +166% | +$314K | 0.07% | 224 |
|
|
2016
Q2 | $220K | Buy |
+2,958
| New | +$220K | 0.03% | 305 |
|